- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED FIELD TRIAL...
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED FIELD TRIAL TO COMPARE THE EFFICACY OF ARTESUNATE AND PRAZIQUANTEL COMBINATION DRUG THERAPY
Despite efforts to contain the disease, Schistosomiasis remains
one of the severe debilitating illnesses in millions of people.
Although it has a relatively low mortality rate, it has a high
morbidity rate, causing schistosomiasis to often be a chronic
illness that can cause liver and intestinal damage. The disease is
mainly found in tropical countries in Africa, Caribbean, eastern
South America, East Asia and in the Middle East. The World Health
Organisation estimates that about 207 million people have the
disease, 120 million symptomatic. There are five species of
flatworms that cause schistosomiasis. Each type is prevalent in
different parts of the world. S. haematobium, is the most
virulent parasite in Africa and the Middle East.
6. Health and safety
All safety data should be listed highlighting clinical
laboratory values outside the normal range. A COSHH form is
attached for the use of formalin.